Giuseppina Rea

Targeting CXCR4 potentiates anti-PD-1 efficacy modifying the tumor microenvironment and inhibiting neoplastic PD-1

Crescenzo D’Alterio, Maria Buoncervello, Caterina Ieranò et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 105 citations · Full text

NLRP3 as Putative Marker of Ipilimumab-Induced Cardiotoxicity in the Presence of Hyperglycemia in Estrogen-Responsive and Triple-Negative Breast Cancer Cells

Vincenzo Quagliariello, Michelino De Laurentiis, Stefania Cocco et al. · International Journal of Molecular Sciences · 2020 · 81 citations · Full text

High Glucose, Lipid Peroxidation, Immunology +18

In PD-1+ human colon cancer cells NIVOLUMAB promotes survival and could protect tumor cells from conventional therapies

Caterina Ieranò, Dario Righelli, Crescenzo D’Alterio et al. · Journal for ImmunoTherapy of Cancer · 2022 · 60 citations · Full text

Conditioned medium of primary lung cancer cells induces EMT in A549 lung cancer cell line by TGF-ß1 and miRNA21 cooperation

Rosa Camerlingo, Roberta Miceli, Laura Marra et al. · PLoS ONE · 2019 · 39 citations · Full text

Tumor Biology, Epithelial-mesenchymal Transition, Conditioned Medium +13

Sphingosine‐1‐phosphate/TGF‐β axis drives epithelial mesenchymal transition in asthma‐like disease

Maria Antonietta Riemma, Ida Cerqua, Barbara Romano et al. · British Journal of Pharmacology · 2021 · 34 citations · Full text